Tweet
Alcobra Announces Enrollment of First Patient in Phase IIb Clinical Trial of MDX ... Wall Street Journal TEL AVIV, Israel, Sept. 2, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity ... and more » |
More...